Becton Dickinson (BDX) revenue: $21.8B
Becton Dickinson reported $21.8B of revenue for the year ended Sep 30, 2025, up 8.2% from $20.2B a year earlier.
From Becton Dickinson's filings with the SEC · Read the filing · BDX stock page
Becton Dickinson revenue by year
#214 of 3,623 US companies by revenue · See the full ranking
| Year ended | Revenue | Change |
|---|---|---|
| Sep 30, 2025 | $21.8B | +8% |
| Sep 30, 2024 | $20.2B | +4% |
| Sep 30, 2023 | $19.4B | +3% |
| Sep 30, 2022 | $18.9B | -1% |
| Sep 30, 2021 | $19.1B | – |
Revenue of similar companies
Companies in the same industry as Becton Dickinson, by SEC industry code, with the closest revenue. Each name opens the same page for that company.
| Company | Revenue, latest year | Year ended |
|---|---|---|
| Medline | $28.4B | Dec 31, 2025 |
| Stryker | $25.1B | Dec 31, 2025 |
| 3M | $24.9B | Dec 31, 2025 |
| Becton Dickinson | $21.8B | Sep 30, 2025 |
| Boston Scientific | $20.1B | Dec 31, 2025 |
| Baxter International | $11.2B | Dec 31, 2025 |
| Solventum | $8.3B | Dec 31, 2025 |
Questions and answers
What is Becton Dickinson's revenue?
Becton Dickinson reported $21.8B of revenue for the year ended Sep 30, 2025, up 8.2% from $20.2B a year earlier.
Numbers as reported in Becton Dickinson's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology